plasma; CRC tissues; corresponding normal tissues (NAT); adjacent tissues
-
Wnt/beta-catenin (other); Hippo/YAP (other); proliferation (other); metastasis (other); apoptosis (other); ceRNA regulation (other); immune regulation (other); other pathway/process (other)
Microarray; RT-qPCR; Clinical Sample Validation; ROC Analysis; Bioinformatics Analysis
Plasma circ-CCDC66 shows high diagnostic accuracy for CRC (AUC 0.920) and improves diagnostic efficacy when combined with CEA and CA19-9; plasma circ-CCDC66 levels are positively correlated with lymph node metastasis, nerve invasion, tumor size, and TNM staging.
Plasma circ-CCDC66 is up-regulated in colorectal polyps and colorectal cancer and shows strong diagnostic performance (AUC 0.920), further improved when combined with CEA and CA19-9. Bioinformatics analyses construct a circ-CCDC66-miRNA-mRNA (ceRNA) network suggesting potential involvement in CRC-related pathways and processes.
0.5047
Exploring the diagnostic potential of plasma circ-CCDC66 in colorectal cancer.
combined biological and clinical study